Access! 2023 + IGBA 2023 Conference - Last chance to register, join us in Orlando, FL on Feb 13-16!

Fireside Chat with Mark Cuban

Join us in Orlando, Florida on February 13-16, 2023 for a fireside chat with Mark Cuban, the founder of the Mark Cuban Cost Plus Drug Company at Access! 2023. Register now!

View Agenda
2021 Savings for Patients by Condition

Generic and biosimilar medicines improve access and affordability for the millions of people with illnesses like asthma, arthritis, heart disease, and depression. Learn more and download fact sheets about the savings by common patient conditions.

Read Blog
Access! 2023 and 25th IGBA Conference

Two Conferences – One Location. Make plans to attend Access! 2023 and the 25th IGBA conference, February 13-16 in Orlando, Florida. Meet the leaders and decision-makers who are shaping the future of generics and biosimilars.

Register Now
2022 U.S. Generic & Biosimilar Medicines Savings Report

Savings continue to grow with $373B saved in 2021 the U.S. health care system, including patients, employers, and taxpayers. With 91% of Rx filled and only 18% of Rx drug spending, findings reinforce the critical importance of the generic and biosimilar industry to America’s patients.

Read Press Release
Explosive Growth in Drug Discount Cards is a Symptom of a Broken System

A new white paper from IQVIA shines light not only on the growth of these cards, but also on how much patients are unnecessarily spending on low-cost generic drugs.

Read Blog
AAM Voices of Access

Physicians, pharmacists, patients and caregivers across the country trust generics and biosimilars. Here are their stories, in their own words—along with perspectives from health care professionals and the AAM team.

View Report
Who’s Profiting from Your Prescription?

Unlike brand drugs where the manufacturer stands to profit the most, generic medicines are often exploited by middlemen that seize significant profits at the expense of patients and the companies that make the medicines.

Learn More

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers of generic and biosimilar medicines and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of generic and biosimilar medicines and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Policy

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable generic and biosimilar medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Jan 26, 2023 | Erica Klinger

AAM Opposes HF17 Which Puts Generic and Biosimilars Savings At Risk for Minnesota Patients

AAM Report: Middlemen Block Patient Access to New Generics

Jan 23, 2023 | Susan Reilly

Study Finds Middlemen Increasingly Block Patient Access to New Generics

Desi, MD | Autoimmune disease

Jan 5, 2023 | Erica Klinger

Desi is Back Playing Soccer and Doing "Normal Kid" Stuff

Group of Patients

Jan 3, 2023 | Sara Skubikowski

Generics and Biosimilars Offer Savings for Patients Fighting Cancer, Heart Disease and Other Conditions

AAM - Your Generics & Biosimilars Industry

Dec 21, 2022 | Craig Burton

Ensuring Patient Access to Amoxicillin When Demand is High

Capitol Building - Washington D.C.

Dec 20, 2022 | Susan Reilly

AAM Statement on the Consolidated Appropriations Act of 2023